h METHODS: We examined measures of disease-specific and generic HRQOL in 164 subjects with chronic lung disease before and after pulmonary rehabilitation. Subjects completed 2 disease-specific [SOBQ, Chronic Respiratory Questionnaire (CRQ)], and 2 generic HRQOL measures [RAND-36 and Quality of Well-Being Scale (QWB)]. The MCID was calculated using 3 methods: effect size, standard error of the measurement (SEM), and comparison between the SOBQ and CRQ Dyspnea scores.
h RESULTS: HRQOL measures correlated moderately with measures of maximum exercise tolerance but not with lung function (FEV 1 , FVC). HRQOL and exercise capacity improved significantly after pulmonary rehabilitation. A change of 5 units for the SOBQ appears to be a reasonable MCID for this instrument. The calculated MCIDs for the CRQ (0.47/item) and QWB (0.031) were consistent with established change scores.
h CONCLUSIONS: The MCID calculated using an SEM approach for the SOBQ, CRQ, and QWB meets clinical expectations for these instruments. HRQOL measures provide information that is complementary and distinct from physiological measures.
Health-related quality of life (HRQOL) has become increasingly important in evaluating health outcomes for patients with chronic lung disease. Interpreting and using such measures is challenging given the variety of questionnaires, each with unique characteristics and scoring methods. Unless one is familiar with a particular instrument, making sense of a change in score is difficult.
Estimating the clinical importance of a change in score is relevant to clinicians and patients. The minimal clinically important difference (MCID) has been defined as the smallest difference that patients perceive to be beneficial. 1 This difference may be larger than statistically detectable change. Various approaches have been developed for defining MCID including anchor-based (related to an independent standard) and distribution-based (related to the underlying distribution in a population) methods, but no single approach has been clearly established as best. 2, 3 Typically, a variety of methods are applied in an attempt to arrive at a consistent estimate for MCID.
Outcome measures in clinical research in pulmonary diseases have traditionally relied upon physiologic parameters (eg, lung function, exercise tolerance). Measurement of symptoms such as dyspnea is important, but because of the complex determinants of dyspnea, changes in breathlessness are often independent of physiologic measures. 4Y7 In recent years, HRQOL measures have been used more frequently. These questionnaires incorporate multiple dimensions of health into one or a few number of measures. Disease or symptomspecific instruments may be most sensitive to change, have been developed for chronic lung diseases, and are designed to capture changes in key pulmonary symptoms and other health dimensions. Generic HRQOL instruments measure particular generalizable dimensions of health applicable to a variety of disease states, but may not be sensitive to important but modest changes in health, in particular, diseases. In pulmonary rehabilitation, for instance, generic instruments are typically less responsive than disease-specific ones. 8 However, much still needs to be learned about the optimal methods of measuring HRQOL in pulmonary patients. 9 The overall objectives of this study are to determine an MCID for the UCSD Shortness of Breath Questionnaire (SOBQ) and compare the MCID for the SOBQ to other HRQOL instruments. 
Subjects and Outcome Measures
Data were obtained from 164 subjects with moderate to severe chronic lung disease enrolled in a clinical trial of maintenance after pulmonary rehabilitation. 10 Baseline characteristics are presented in Table 1 . Analyses were performed with pooled data from all subjects before and after rehabilitation prior to randomization, since the experimental maintenance intervention was initiated only after the post-rehabilitation evaluation. The pulmonary rehabilitation program involved sixteen 3-hour sessions conducted over 8 weeks and included components of exercise reconditioning, education, physical and respiratory care instruction, and psychosocial support. Physiologic measures included tests of lung function, exercise tolerance, and gas exchange. Five separate HRQOL measures were obtained, including both disease/symptom-specific (SOBQ, 11 17 and self-efficacy for walking. 8 
UCSD Shortness of Breath Questionnaire
The SOBQ asks subjects to indicate severity of shortness of breath on a 6-point scale (0 = Not at all, I, 5 = Maximally or unable to do because of breathlessness) during 21 activities of daily living associated with varying levels of exertion. Three additional questions ask about fear of harm from overexertion, limitations, and fear caused by shortness of breath, for a total of 24 items. If patients do not routinely perform an activity, they are asked to estimate their anticipated shortness of breath. A total sum score ranges from 0 to 120. The SOBQ has been found to have excellent internal consistency, reliability, and moderate-to-strong correlations with measures of exercise tolerance, disease severity, depression, and perceived breathlessness ratings following a 6-minute walk test (6MW).
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Statistical Analysis
Data before and after rehabilitation were evaluated with descriptive statistics and paired t tests for changes. Change scores were calculated from pre-to postrehabilitation. Pearson correlation coefficients were used to evaluate relationships among variables. Values are expressed as mean T SD.
There was no change after the rehabilitation program significant at P G .05.
using Cronbach ". For effect size, changes before and after rehabilitation were divided by the standard deviation (SD) of the baseline score. The magnitude of the effect size was judged according to criteria described by Cohen (0.2 = small, 0.5 = moderate, 0.8 = large).
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The SEM was estimated according to the following
, where G = the SD and r xx = its reliability coefficient. The criterion of one SEM was used to define MCID. 20 In order to validate the one SEM criterion, the SOBQ was categorized according to change after rehabilitation by change in SEM (improved = decrease Q1 SEM; same = G1 SEM change; worse = gain Q1 SEM) and was cross-classified with the CRQ Dyspnea scores according to previously established MCID.
1 A weighted-Kappa statistic was used to assess the rank agreement between the scores.
Comparison of the change in SOBQ and CRQ Dyspnea score versus the TDI was performed using a receiver-operator curve (ROC) analysis to evaluate the sensitivity (and specificity) of change in SOBQ (and CRQ Dyspnea) in determining a 1-unit change in TDIVby definition a change in symptoms that can be detected by patients. 21 Prior to data analysis, 3 researchers/clinicians experienced in using the SOBQ were asked individually (without prior discussion) to estimate what change they considered to be clinically significant. 
Descriptive Statistics
The baseline psychometric properties of the HRQOL instruments are listed in Table 2 . The SOBQ was found to be normally distributed. Most instruments had reliability scores (Cronbach ") greater than 0.80, except the CRQ's dyspnea, mastery, and RAND/SF-36's general health and social functioning domains. As reported in previous studies, about half of the RAND/SF-36 domains (Bodily pain, Role Physical, Role Emotional and Social Functioning) exhibited floor and ceiling effects: 25% or more of the subjects reported the highest or lowest possible score. 22, 23 The HRQOL baseline scores are significantly lower than population norms. 24 Correlations between baseline variables are displayed in Table 3 . Correlations were highest between variables in the same categories (spirometry, exercise capacity, and HRQOL). Although HRQOL measures were not significantly correlated with spirometric variables (FEV 1 and FVC), associations with exercise . ............................................................................................................................................................................................................................ ..... 
Pulmonary Rehabilitation Effect
Changes after pulmonary rehabilitation are presented in Table 4 . Although lung function did not change, HRQOL and exercise capacity improved significantly after the 8-week program. The statistically significant changes for the CRQ domains and QWB also met established criteria for clinical significance (0.5 units per question for the CRQ, 25,26 0.03 for QWB 27 ). Although the change in 6MW was statistically significant, it did not reach the generally defined clinically meaningful difference of 54 meters. 28 
Effect Size
Effect sizes are also shown in Table 4 . The largest effect sizes were seen with the CRQ domains (range of 0.44 to 0.99). Moderate to large effect sizes (90.5 and 90.8, respectively, as defined by Cohen 19 ) were also seen for the SOBQ and several of the RAND/SF-36 subscales (Physical functioning, Role-physical, Energy/fatigue, and Health change). Most other effect sizes were in the small to moderate range (0.2 to 0.5).
Standard Error of Measurement
As suggested by Wyrwich et al, 29 we considered one SEM as a minimal clinically significant difference score. For the SOBQ, one SEM was 5.0 units ( Table 2) . This was consistent with the meaningful clinically significant change estimated by individuals familiar with the instrument. The one SEMs (per question) for the individual CRQ domains were as follows: dyspnea 0.52, emotional function 0.35, fatigue 0.42, and mastery 0.60 ( Table 2 ). The average SEM for the 4 CRQ domains was 0.47. This is similar to the established 0.5 change for MCID suggested by Redelmeier. 26 The SEM for the QWB was 0.031, consistent with that instrument's established change score. 27 
SOBQ Versus CRQ Dyspnea
Change after rehabilitation in SOBQ correlated moderately with change in the CRQ Dyspnea domain (j0.43). Neither the SOBQ nor the CRQ Dyspnea change score was correlated with change in 6-minute walk distance or maximum treadmill workload (METS max ).
The SOBQ and CRQ Dyspnea scores were classified by change after pulmonary rehabilitation according to the already established MCID for CRQ Dyspnea and the suggested 5-unit change for SOBQ. Each subject's change was categorized as improved, worsened, or unchanged after rehabilitation. Weighted kappa of .. ........................................................................................................................................................................................................................... ..... agreement was 0.11 (0.06 asymptotic standard error), which confirms that these two instruments statistically had poor general agreement (perfect agreement is 1, no agreement is 0). Table 5 presents the cross-tabulation of changes comparing the SOBQ and CRQ Dyspnea Scale. One hundred three subjects improved according to the SOBQ versus 111 in CRQ Dyspnea; 77 (48%) improved in both. The two instruments agreed in 90 cases (56%). In 13 cases (8%), improvement was noted in the CRQ while the SOBQ worsened. In 2 (1%) cases, the SOBQ score improved when the CRQ Dyspnea score worsened. Figure 1 presents results of the ROC analysis of changes in the SOBQ and CRQ Dyspnea versus the TDI after pulmonary rehabilitation. 10 Assuming that a threshold of 1-unit change in the TDI represents a noticeable change in symptoms and is a reasonable MCID, 21 this analysis suggests that a change in SOBQ of j5 units (improvement) is associated with a sensitivity and specificity of approximately 69% and 67%, respectively, in detecting a 1-unit improvement in TDI. Overall, as indicated in Figure 1 , a change of 0.5 to 0.6 units in the CRQ Dyspnea domain was comparable to a 4-to 6-unit change in the SOBQ. The results of this study suggest that a change in the SOBQ of 5 units is a reasonable estimate of the MCID for this questionnaire. This MCID was developed by systematic evaluation of several approaches in a patient cohort in response to a pulmonary rehabilitation intervention including comparison with similar instruments (anchor-based), distribution-based analysis, and a priori estimate by experienced users.
Users familiar with a test intuitively know through experience the relative value of a particular result. Statistically significant changes may not indicate clinically meaningful differences such as with small changes in large sample sizes. Unfortunately, there is no gold standard with which to establish MCID for a new instrument.
The complexities of methods used to evaluate responsiveness have been reviewed 30 and there does not appear to be a consensus on a single approach to arrive at an MCID. Wyrwich et al 20, 29 proposed the one-SEM criterion for MCID. This was successfully crossvalidated with the patient-driven MCID in previous studies using the CRQ. Similar findings in an anchorbased method (eg, global change on a 7-point scale) and distribution-based approach (effect size calculation) have been demonstrated. 31 ,32 Jaeschke et al 1 described a technique comparing a global measure of change (worse, about the same, or better using a 7-point scale) to the CRQ and arrived at an MCID score. Harper et al 23 also used a global question (modified version of item 2 of the SF-36) comparing a subject's health ''now'' to a specified earlier occasion as a standard for assessing responsiveness and MCID. Redelmeier et al 26 used a method requiring patients to judge themselves relative to others with the same condition and arrived at a similar MCID as the previous study with patients judging themselves according to their own memory approach. Norman et al, 33 though, asserted that global assessments of change can be associated with a recall bias that correlates highly with the present state of health but poorly with a previous one. Other methods include standardized effect sizes such as were calculated for the CRQ, SGRQ, SF-36, and Euroqol by dividing the mean change between assessments by the standard deviation of the change. Effect sizes varied with instrument, domain, and time interactions. 23 The SEM approach is a distributional approach that seems to be valid and yields similar results to other methods. The findings in this study using an SEM-based method yielded similar results for the CRQ and QWB to previously established thresholds.
The categorization of CRQ and SOBQ by significant change produced generally poor agreement, which highlights the difficulty in validating such measures. Although both questionnaires evaluate the broad concept of dyspnea, there are important differences between them. In this study, the CRQ Dyspnea scale was administered by an interviewer and was based upon specific activities selected by each individual. The SOBQ, on the other hand, asks subjects to report dyspnea associated with a standard set of activities. These discrepancies make it difficult to compare scores directly. Most cases of disagreement between the SOBQ and CRQ occurred when one instrument failed to detect change measured by the other. In 15 subjects, the two instruments detected changes in the opposite direction. In the majority of these (13) , the CRQ Dyspnea score improved while the SOBQ score worsened, whereas the opposite occurred in only 2 subjects.
. ....................................................................................................... ..... Ongoing evaluation of validity is important in developing an outcome measure as it is applied to an increasing variety of patient populations and situations. As with all new tests, these tools should be tested and compared to existing gold standard techniques. HRQOL questionnaires should meet these primary criteria: (1) validity: questionnaires should measure what they intend to measure (ie, scores reflect true domains to be evaluated); (2) reliability: the extent to which an instrument yields consistent, reproducible results; and (3) responsiveness: sensitivity of a questionnaire to measure change when such change has legitimately occurred (eg, after a treatment intervention). Researchers using these tools frequently gain an appreciation from their own experience as to what constitutes a meaningful change. Defining MCID allows those less familiar with the instrument to better interpret results.
The SOBQ, CRQ, and QWB had good psychometric properties in this analysis. These HRQOL measures are relatively easy to administer. They did not exhibit limiting floor or ceiling effects, and had acceptable reliability. Although the discriminative properties of the instruments were not formally tested, HRQOL levels in these patients with moderate to severe COPD were substantially lower than in healthy controls. 24 The RAND/SF-36 also had acceptable psychometrics, but as noted in previous studies, some of the individual domains were skewed at either end of the spectrum. 22, 23 This nonnormal distribution might be expected with a generic measure not designed specifically for chronic lung disease. Further, floor or ceiling effects were noted for half of the RAND/SF-36 scales. The summary physical and mental component scores eliminate floor and ceiling effects and limit problems of multiple comparisons while still maintaining validity. 34 Further construct validity was evident with the expected changes in the appropriate direction with improvement after pulmonary rehabilitation.
Pulmonary rehabilitation has been well-established in the management of patients with chronic lung diseases. Benefits include improved exercise tolerance, symptoms, and quality of life with decrease in healthcare expenditures.
35Y37 Pulmonary rehabilitation is an ideal intervention to evaluate HRQOL as the treatment and possible outcomes are multidimensional (eg, physiological, psychological, and social). Medical interventions often work through physiological changes to improve patient function. However, a treatment that improves lung function with no effect on symptoms or quality of life may be suspect. Conversely, an intervention with less impact on lung function, but more improvement in symptoms or quality of life, might be more important. Several studies have evaluated HRQOL in pulmonary rehabilitation with disease-specific or general instruments. 35 ,38Y40 More recent studies have used both generic and disease-specific instruments in the same cohort. 10, 23, 41, 42 Although results vary, as expected, generic measures have generally been less sensitive to change after pulmonary rehabilitation. 8, 41, 43 In this study, responsiveness was demonstrated in all of the HRQOL measures after pulmonary rehabilitation, with the exception of the RAND/SF-36 Pain subscale. As expected, lung function did not change. This highlights the limitation of using classic physiologic indices as outcome measures in this setting. The responsiveness observed in this study adds to the overall validity of these instruments.
Determining the most sensitive instrument to detect change can be difficult. By design, disease or symptom-specific instruments, such as the CRQ and SOBQ, should be responsive and discriminative in COPD. Both were responsive to change after pulmonary rehabilitation with moderate effect sizes, larger with the CRQ than the SOBQ. The generic instruments were less responsive to change, with the QWB just achieving the estimated MCID. 41 The limitations in responsiveness for such instruments may be offset by gains in comparability between disease states and their use in cost-utility studies. There is also the added advantage that generic instruments may detect either beneficial or deleterious effects from treatment that might not be anticipated or measured with a diseasespecific instrument. These findings support the notion that both disease-specific and generic instruments of HRQOL should be used together.
Comparison between different measures of HRQOL is always difficult because no gold standard truly exists. Differences between seemingly similar measures may well be due, in part, to the diverse components of HRQOL being assessed.
In summary, disease-specific and generic measures of HRQOL are important components of health outcome evaluations. Valid and responsive instruments exist for chronic lung disease and pulmonary rehabilitation. The proposed MCID of 5 units for the SOBQ compared favorably to thresholds established for other HRQOL instruments in this patient population under study.
